NEFL and tropical spastic paraparesis: In vitro treatment with mogamulizumab significantly reduced the NF-L concentration compared with the negative control (human IgG), indicating the critical role of HTLV-1–infected T cells in HAM-PBMCs in inducing neuronal cell damage (Figure 1B).